Amyris, Inc.’s joint venture with the Nikkol Group, Aprinnova, has launched pharmaceutical grade Neossance Squalane USP. This new material meets the industry standards required by the United States Pharmacopeia (USP) and the National Formulary (NF) for drug actives and pharmaceutical excipients, which are used by regulatory agencies and manufacturers. As a result, Aprinnova is now able to supply these industries with FDA-regulated sugarcane-derived squalane, which was previously unavailable to t...